SCINTIX™ therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease.
When radiopharmaceuticals are introduced into the body, cancer cells absorb them and create a biological beacon, which our machine uses to manage motion and treat solid tumors of any stage disease.
Learn About Emissions
Our SCINTIX technology delivers high doses of radiation to tumors, even those in motion. Live targeting allows for greater impact to the tumor and potentially less dose to surrounding tissues.
Learn About Targeting
Most patients with stage four cancer are not considered candidates for definitive radiotherapy. Our breakthrough SCINTIX therapy creates a new option for patients with lung or bone tumors arising from primary or metastatic cancer.
Discover the Potential
Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. Adding SCINTIX therapy to chemotherapy, immunotherapy and targeted drugs may potentially improve outcomes.
Learn About Treatment
By combining PET-CT and radiotherapy, we're able to find and treat cancer using emissions created by tumors themselves.
Discover SCINTIX therapy.
See how SCINTIX therapy can play a role
in your cancer program.
Sale expands northeastern U.S. footprint of FDA-cleared SCINTIX therapy for early and late-stage cancers HAYWARD, Calif., Mar 1, 2023 – RefleXion Medical, Inc., a therapeutic oncology company, today announced the installation of its RefleXion® X1 platform at Smilow Cancer Hospital, part of Yale New Haven Health, Connecticut’s largest healthcare system. SCINTIX™ biology-guided radiotherapy, cleared by […]
It sounds like the stuff of science fiction: a technology that can detect the biological activity of cancer cells in the body and direct targeted beams of energy to destroy tumors in real-time. That vision is now a reality, and with it, a new day has dawned for cancer care. The milestone moment occurred in […]
Let us tell you more.
Contact UsStay up to date.
Sign Up